Care for Patients Undergoing Current Cancer Treatments
To achieve optimal care, we:
Provide information and support for skillful decision making. A person with cancer often faces a bewildering number of choices of conventional treatments, treatment centers, as well as complementary and alternative treatments. Good information and coaching can help guide optimal choices in all of these areas.
Address the patient’s overall well-being– physical, emotional and spiritual health. We investigate and treat nutritional, metabolic (anabolism/catabolism) digestive, energetic, endocrine, and immune balance. Our goals are to strengthen the patient’s constitution and immune system, boost vital energy, minimize side effects and the negative impact of necessary medical treatments, improve quality of life and overall health and extend the life span. Botanicals (herbs), nutrition and exercise are essential parts of this work
Assess the patient’s “terrain” and the tumor micro-environment- this is what the tumor is altering in order to facilitate growth and spread. We aim for the nutritional and biochemical environment that is least hospitable to cancer and most conducive for the patient’s well being. We address blood sugar control, copper concentration, extent of inflammation, etc. We use botanicals (herbs), which “multi-task” to support overall health, optimize the “terrain,” and suppress multiple cancer pathways.
Explore the characteristics of the tumor, when appropriate, with tools such as tumor molecular profiling to identify and target cellular mutations in the tumor. It may be possible to test for drug sensitivity and resistance. This cutting edge approach can be used as a guide to select specific medication– to pick the most favorable drug and timing of administration, as well as herbal and nutritional therapies that are most likely to be effective.
We start each patient with a foundational protocol that makes extensive use of botanical and nutritional therapies to enhance immune response, protect vital organs, potentiate drug therapies, and target specific pathways altered by cancer. This protocol is likely to include: